I recently accepted the challenge to participate in the Timmerman Traverse to support Damon Runyon cancer researchers who are pushing the boundaries of what’s possible. This cause is also deeply personal to me, as I’ve seen cancer impact many relatives and close friends.

In my role as VP of Business and Corporate Development at PhaseV, an AI/ML-powered technology company focused on optimizing clinical trial design and execution, I work alongside a multidisciplinary team supporting biopharma sponsors in bringing new therapies to patients faster and more effectively.

At PhaseV, we’ve supported a number of oncology programs where improvements in trial design and execution, from better patient stratification to faster enrollment, have meaningfully impacted outcomes. Being able to support the researchers behind these breakthroughs is a natural extension of that mission.

Please consider joining me in supporting this effort and raising funds for lifesaving research.